期刊文献+

糖神胶囊工艺改革及量效关系的实验研究

Experimental study of the new tangshen capsule effect and dosage
下载PDF
导出
摘要 目的:比较糖神胶囊普通制剂和不同剂量新工艺制剂的疗效关系。方法:制备链脲佐菌素糖尿病大鼠模型,分别用普通制剂和不同剂量新工艺制剂的糖神胶囊灌胃,观察8周。检测服药前后空腹血糖(FBG)、红细胞中山梨醇(RBCS)的含量、运动神经传导速度(MNCV)、甩尾反射潜伏期(TFL)。结果:与普通制剂相比,新工艺制剂的糖神胶囊可降低链脲佐菌素糖尿病大鼠的FBG、RBCS含量,加快MNCV,延长TFL(P均<0.05)。1/2剂量的新工艺制剂与普通制剂疗效相似。结论:糖神胶囊新工艺制剂可明显提高药效,减少服药剂量。 Objective: To compare the effect of Tangshen capsule's normal preparations with new preparations. Methods: Diabetic rat models induced by streptozotocin administered through intragstricinfusion with normal preparations of Tangshen capsule and different dosages of Tangshen capsule made with new technics respectively, were observed for 8 weeks. The fore-and-aft fasting blood glucose (FBG), content of sorbitol in red cells (RBCS), conduct velocity of the motor nerve (MNCV) and tail flick latency (TFL) were detected. Results: Compared with the normal preparation, the new technical preparations of the Tangshen capsule could reduce the FBG, RBCS, speed up the MNCV and make the TFL longer( P 〈 0.05). Half dosage of the new technical prepartions and full dosage of normal prepartions had the same effect. Conclusion: Tangshen capsule prepared with new technical method markedly improves the effect and reduces dosage of drugs.
出处 《山东大学学报(医学版)》 CAS 北大核心 2006年第8期846-848,852,共4页 Journal of Shandong University:Health Sciences
基金 山东省中医管理局九五攻关课题(95043)
关键词 糖神胶囊 工艺学 制药 山梨醇 大鼠 Wistar Tangshen capsule Technology, pharmaceutical Sorbitol Rats, Wistar
  • 相关文献

参考文献12

  • 1李仪奎.中药药理方法学[M].上海:上海科学技术出版社,1991.459.
  • 2.中华人民共和国药典[M].化学工业出版社,2000年版二部.附录84.
  • 3Nakamura JR.Pathogenesis and treatment of diabetic neuropathy[J].Saishinigaku,2000,55(3):368-374.
  • 4Koya D,King GL.Protein kinase C activation and the development of diabetic complications[J].Diabetes,1998,47(6):859-866.
  • 5Nakamura J,Kato K,Hamada Y,et al.A protein kinase C-B-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats[J].Diabetes,1999,48(10):2 090-2 095.
  • 6Vlassara H,Bucala R,Striker L.Pathogenic effects of advanced glycosylation:biochemical,biologic,and clinical implication for diabetes and aging[J].Lab-Invest,1994,70(2):138-151.
  • 7Takahashi M,Lu YB,Myint T,et al.In vitro glycation of aldehyde reductase,a major 3-deoxyglucosone reducing enzyme:identification of glycation sites[J].Biochemistry,1995,34(4):1 433-1 438.
  • 8Baynes JW.Role of oxidative stress in development of complications in diabetes[J].Diabetes,1991,40(4):405-412.
  • 9Arai K,Maguchi S,Fujii S,et al.Glycation and inactivation of human Cu-Zn-superoxide dismutase.Identification of the in vitro glycated sites[J].J Biol Chem,1987,262(35):16 969-16 972.
  • 10张家庆.关于糖尿病并发症中西医结合治疗及研究[J].中国中西医结合杂志,1996,16(1):3-3.

二级参考文献3

共引文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部